Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare and treatable variant of CAA likely due to an autoimmune response directed toward beta-amyloid deposits. Cognitive and behavioral manifestations are the most common symptoms, followed by focal neurological signs, headache and seizures, associated with characteristics neuroradiological features on brain magnetic resonance imaging (MRI). We describe the clinical course, radiological features and therapeutic approach of two patients with probable CAA-ri with the aim of emphasizing the importance of an early diagnosis of this potentially reversible disease in different neurological settings, such as memory clinics and stroke units.

A challenging diagnosis of reversible "vascular" dementia: Cerebral amyloid angiopathy-related inflammation / Poli, L.; De Giuli, V.; Piazza, F.; Volonghi, I.; Bigliardi, G.; Vallone, S.; Nichelli, P. F.; Gasparotti, R.; Zini, A.; Padovani, A.; Pezzini, A.. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 338:(2020). [10.1016/j.jneuroim.2019.577109]

A challenging diagnosis of reversible "vascular" dementia: Cerebral amyloid angiopathy-related inflammation

Pezzini, A.
2020-01-01

Abstract

Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare and treatable variant of CAA likely due to an autoimmune response directed toward beta-amyloid deposits. Cognitive and behavioral manifestations are the most common symptoms, followed by focal neurological signs, headache and seizures, associated with characteristics neuroradiological features on brain magnetic resonance imaging (MRI). We describe the clinical course, radiological features and therapeutic approach of two patients with probable CAA-ri with the aim of emphasizing the importance of an early diagnosis of this potentially reversible disease in different neurological settings, such as memory clinics and stroke units.
2020
A challenging diagnosis of reversible "vascular" dementia: Cerebral amyloid angiopathy-related inflammation / Poli, L.; De Giuli, V.; Piazza, F.; Volonghi, I.; Bigliardi, G.; Vallone, S.; Nichelli, P. F.; Gasparotti, R.; Zini, A.; Padovani, A.; Pezzini, A.. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 338:(2020). [10.1016/j.jneuroim.2019.577109]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2964690
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 10
social impact